@drjencaudle's 'saggy skin' GLP-1 claim needs context

What did @drjencaudle actually say?

Dr. Jen Caudle used the viral phrase 'Ozempic vagina' as a hook, then immediately corrected the anatomy: it's actually the vulva, the external genitalia, not the vagina itself. Her core argument is straightforward. GLP-1 drugs like semaglutide cause weight loss, fat is stored in the mons pubis and labia majora, losing that fat quickly can leave loose or saggy skin, and that's what people are describing online. She framed it as a physiologically logical consequence of rapid fat loss rather than a drug-specific side effect. She ended with a reasonable disclaimer: talk to your doctor if you have concerns.

The anatomy correction alone puts her ahead of most of the content floating around on this topic. That said, she kept the mechanistic explanation fairly surface-level, which leaves some important nuance on the table.

Does the science back this up?

Yes, the basic mechanism holds up. Fatty tissue does accumulate in the mons pubis and labia majora, and rapid fat loss is a well-documented cause of skin laxity across the body. The physiology here is not controversial.

The mons pubis contains a substantial subcutaneous fat pad. Studies on bariatric surgery patients, who experience fat loss at a scale comparable to GLP-1-assisted weight loss, consistently document skin laxity and excess skin in the pubic region. Gilmore et al. (2019, Aesthetic Surgery Journal) noted that the mons pubis is among the areas patients frequently report changes in after significant weight loss. Collagen degradation also plays a role. Skin elasticity depends on collagen and elastin integrity, and faster weight loss leaves less time for skin to contract, a pattern documented in multiple bariatric outcome studies (Shermak, 2012, Plastic and Reconstructive Surgery). No studies specifically examine vulvar laxity in GLP-1 users as a primary endpoint, so the direct pharmacological link is extrapolated, not confirmed in trial data. That's an important distinction.

What did they get wrong (or right)?

The anatomy correction was right, and credit is due for making it clearly. Calling external genital changes 'vagina' anything is anatomically wrong, and Caudle pushed back on it in plain terms.

What she glossed over is that 'Ozempic vulva' implies something unique to GLP-1 drugs. It isn't. This is a general consequence of significant, rapid fat loss regardless of the method. The same phenomenon occurs after bariatric surgery, aggressive caloric restriction, or other weight loss interventions. Framing it around a brand name, even to debunk it, reinforces the idea that semaglutide is doing something singular here when the mechanism is just weight loss itself. She did nod at this, noting that laxity happens 'in other parts of your body where you're losing weight,' but did not state explicitly that any method causing similar fat loss would produce similar results. That gap matters for informed patients.

She also did not mention that some women report changes in vaginal lubrication or pelvic floor symptoms alongside GLP-1 use, which has a separate, less-understood physiological basis and should not be conflated with vulvar skin laxity.

What should you actually know?

If you are losing significant weight on a GLP-1 medication and noticing changes to your vulvar area, the mechanism is fat loss and skin laxity, not a drug-specific effect targeting that anatomy. That distinction matters because it shapes your options.

Slower, more gradual weight loss gives skin more time to adapt, though genetics determine a lot of how much elasticity any individual has. Options discussed in dermatology and plastic surgery literature for skin laxity in this region include radiofrequency treatments and, in more significant cases, surgical procedures like a monsplasty. None of these are GLP-1 specific. Additionally, if you are experiencing internal vaginal dryness, changes in discharge, or pelvic floor symptoms, those are separate concerns worth raising with a gynecologist or urogynecologist, as the causes and management differ from external skin laxity. Do not assume everything in that region is explained by one mechanism. Caudle's closing advice, check with your doctor, is the right call, though it deserves more specificity about which type of doctor depending on what symptom you are actually experiencing.